Nevro Corp (NVRO) - Financial and Strategic SWOT Analysis Review

Date: March 7, 2019
Pages: 45
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: NCF0DA56C90EN
Leaflet:

Download PDF Leaflet

Nevro Corp (NVRO) - Financial and Strategic SWOT Analysis Review
Nevro Corp (NVRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Nevro Corp (Nevro) is a medical device company which focuses on providing novel products that advance the quality of life of people suffering from chronic pain. The company has developed Nevro Senza spinal cord stimulation (SCS) system, a non-pharmacologic neuromodulation platform for the treatment of chronic pain. The Nevro Senza SCS system is commercially available in the US, Europe and Australia. The company offers products under Senza, Senza II, HF10, Nevro and the Nevro logo brands. Nevro is developing HF10 therapy for treating painful diabetic neuropathy and non-surgical refractory back pain. Nevro is headquartered in Redwood City, California, the US.

Nevro Corp Key Recent Developments

Feb 21,2019: Nevro reports fourth quarter and full year 2018 financial results
Feb 21,2019: Stimwave addresses patent infringement lawsuit brought by Nevro
Jan 07,2019: Nevro announces preliminary unaudited fourth quarter and full year 2018 revenue
Nov 05,2018: Nevro Reports Third Quarter 2018 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

NOTE: Out of security concerns GlobalData requires using corporate email address.
SECTION 1 - ABOUT THE COMPANY

Nevro Corp - Key Facts
Nevro Corp - Key Employees
Nevro Corp - Key Employee Biographies
Nevro Corp - Major Products and Services
Nevro Corp - History
Nevro Corp - Company Statement
Nevro Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Nevro Corp - Business Description
Product Category: Senza System
Performance
Geographical Segment: International
Target Markets
Performance
Geographical Segment: United States
Performance
R&D Overview
Nevro Corp - Corporate Strategy
Nevro Corp - SWOT Analysis
SWOT Analysis - Overview
Nevro Corp - Strengths
Nevro Corp - Weaknesses
Nevro Corp - Opportunities
Nevro Corp - Threats
Nevro Corp - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Nevro Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Nevro Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Nevro Corp, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 21, 2019: Nevro reports fourth quarter and full year 2018 financial results
Feb 21, 2019: Stimwave addresses patent infringement lawsuit brought by Nevro
Jan 07, 2019: Nevro announces preliminary unaudited fourth quarter and full year 2018 revenue
Nov 05, 2018: Nevro reports third quarter 2018 financial results
Nov 05, 2018: Nevro Reports Third Quarter 2018 Financial Results
Aug 02, 2018: Nevro reports second quarter 2018 financial results
Jul 30, 2018: Nevro Announces Update on Patent Litigation
Jul 25, 2018: Nevro Announces Patent Litigation Update
Jul 16, 2018: Nevro Announces Preliminary Unaudited Second Quarter 2018 Revenue and Updates Full Year 2018 Revenue Guidance
May 14, 2018: Nevro Recognized as a"Best Place to Work" in the Bay Area

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Nevro Corp, Key Facts
Nevro Corp, Key Employees
Nevro Corp, Key Employee Biographies
Nevro Corp, Major Products and Services
Nevro Corp, History
Nevro Corp, Subsidiaries
Nevro Corp, Key Competitors
Nevro Corp, Ratios based on current share price
Nevro Corp, Annual Ratios
Nevro Corp, Annual Ratios (Cont.1)
Nevro Corp, Interim Ratios
Nevro Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Nevro Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Nevro Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Nevro Corp, Performance Chart (2014 - 2018)
Nevro Corp, Ratio Charts
Nevro Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Nevro Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019

COMPANIES MENTIONED

Abbott Laboratories
Boston Scientific Corp
Medtronic Plc
NeuSpera Medical Inc
Saluda Medical Pty Ltd
Stimwave Technologies, Inc.
Skip to top


Ask Your Question

Nevro Corp (NVRO) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: